Markets:

Overview

News

Currencies

International

Treasuries

Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

1.820 +0.010 (+0.55%)

Streaming Delayed Price Updated: 9:50 AM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Innate Pharma S.A. - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress

December 09, 2021

From Innate Pharma S.A.

Via Business Wire

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

Innate Pharma to Present Monalizumab Data at ESMO Immuno-Oncology 2021 Congress

December 02, 2021

From Innate Pharma SA

Via Business Wire

Innate Pharma to Participate in the Evercore ISI 4th Annual HealthConX Virtual Conference

November 24, 2021

From Innate Pharma SA

Via Business Wire

Innate Pharma Third Quarter 2021 Report

November 16, 2021

From Innate Pharma S.A.

Via Business Wire

Innate Pharma Announces Conference Call and Webcast for Q3 2021 Business Update

November 09, 2021

From Innate Pharma SA

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 01, 2021

Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's pre-market session. The company's market cap stands at $27.1...

Via Benzinga

Innate Pharma 2022 Financial Calendar

October 26, 2021

From Innate Pharma SA

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 25, 2021

Gainers Medpace Hldgs (NASDAQ:MEDP) shar...

Via Benzinga

Number of Shares and Voting Rights of Innate Pharma as of October 1, 2021

October 15, 2021

From Innate Pharma

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 30, 2021

Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The company's market cap stands at $1.4 billion....

Via Benzinga

18 Stocks Moving in Thursday's Pre-Market Session ↗

September 30, 2021

Gainers Superior Drilling Products, Inc. (NYSE: SDPI) rose 58.7% to $1.73 in pre-market trading after jumping over 23% on Wednesday. The company, last month, reported Q2...

Via Benzinga

50 Biggest Movers From Yesterday ↗

September 22, 2021

Check out these big penny stock gainers and losers Losers Edesa Biotech, Inc. (NASDAQ: EDSA) shares dipped 29.9% to close at $8.36 on profit-taking after the stock...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 21, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 30.95% to $8.08 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

32 Stocks Moving In Tuesday's Mid-Day Session ↗

September 21, 2021

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 177.4% to $39.83. Helbiz Media, the media arm of Helbiz announced a deal with Amazon Italy, a unit of Amazon.com. ReWalk...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 21, 2021

Gainers Viridian Therapeutics (NASDAQ:VRDN) shares rose 18.05% to $12.62 during Tuesday's pre-market session. The company's market cap stands at $120.9 million....

Via Benzinga

18 Stocks Moving in Tuesday's Pre-Market Session ↗

September 21, 2021

Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44...

Via Benzinga

48 Biggest Movers From Friday ↗

September 20, 2021

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by...

Via Benzinga

Global Radiotherapy Market Expected To Reach $7.3 Billion with a CAGR Of 4.2% By 2026

September 20, 2021

Via FinancialNewsMedia

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 17, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet ↗

September 17, 2021

Toward the end of trading Friday, the Dow traded down 0.47% to 4,587.22 while the NASDAQ fell 1.05% to 15,023.11. The S&P also fell, dropping 0.85% to 4,435.65. The U.S. has...

Via Benzinga

Topics Stocks

Here's Why Innate Pharma Stock Is Rocketing Higher Today ↗

September 17, 2021

A clinical trial with an experimental lung cancer drug produced some positive results.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 17, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS

Via Benzinga

Mid-Day Market Update: Crude Oil Falls Over 1%; Helbiz Shares Spike Higher ↗

September 17, 2021

Midway through trading Friday, the Dow traded down 0.51% to 34,572.50 while the NASDAQ fell 0.78% to 15,062.99. The S&P also fell, dropping 0.72% to 4,441.64. The U.S. has the...

Via Benzinga

Topics Stocks

Mid-Morning Market Update: Markets Down; US Consumer Sentiment Edges Higher ↗

September 17, 2021

Following the market opening Friday, the Dow traded down 0.37% to 34,622.25 while the NASDAQ fell 0.58% to 15,094.19. The S&P also fell, dropping 0.55% to 4,449.03. The U.S....

Via Benzinga

Topics Stocks

What Is Happening With Innate Pharma Stock On Friday? ↗

September 17, 2021

Innate Pharma SA (NASDAQ: IPHA) stock is trading at a 52-week high as its partner AstraZeneca Plc (NASDAQ: AZN) presented results from the COAST Phase 2 trial...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 17, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 53.98% to $3.48 during Friday's pre-market session. The company's market cap stands at $147.6...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

September 17, 2021

UBS cut FedEx Corporation (NYSE:FDX) price target fr...

Via Benzinga

15 Stocks Moving in Friday's Pre-Market Session ↗

September 17, 2021

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) rose 42% to $3.21 in pre-market trading. AbCellera Biologics Inc. (NASDAQ: ABCL) rose 18% to $23.35 in pre-market trading....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 15, 2021

Gainers Indaptus Therapeutics (NASDAQ:INDP) shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.